• 1.

    Johansen KL, et al.; Conference Participants. Central and peripheral arterial diseases in chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2021; 100:3548. doi: 10.1016/j.kint.2021.04.029

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Bobot M, et al. Kidney disease and stroke: Epidemiology and potential mechanisms of susceptibility. Nephrol Dial Transplant (published online ahead of print February 8, 2023). doi: 10.1093/ndt/gfad029; https://academic.oup.com/ndt/advance-article-abstract/doi/10.1093/ndt/gfad029/7031767?redirectedFrom=fulltext&login=false

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Saber H, et al. Reperfusion therapy frequency and outcomes in mild ischemic stroke in the United States. Stroke 2020; 51:32413249. doi: 10.1161/STROKEAHA.120.030898

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Anderson CS, et al.; ENCHANTED Investigators and Coordinators. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 2016; 374:23132323. doi: 10.1056/NEJMoa1515510

    • PubMed
    • Search Google Scholar
    • Export Citation

Stroke in Patients with Kidney Diseases: A Not-So-Silent Killer?

Rasha Raslan Rasha Raslan, MD, is with the Division of Nephrology, Department of Medicine, Duke University Hospital, Durham, NC.

Search for other papers by Rasha Raslan in
Current site
Google Scholar
PubMed
Close
Restricted access
Save